Pemphigus, an autoimmune mucocutaneous disease characterized by antibodies against desgmoglein (Dsg) proteins on the cell surfaces of epidermal keratinocytes, can be sub-classified into its two major forms as vulgaris (PV) and foliaceus (PF). The difference between the two is the antibody target; in PV the antibody response is against Dsg3, whereas in in PF the antibodies are against Dsg. Because of the different targets, the clinical presentations are usually somewhat different. Both conditions present as superficial vesicles and bullae, but the vesicles of PF are more superficial, often ruptured, and mucosal involvement is seen less often. The most common histologic findings are suprabasilar or subcorneal acantholysis respectively. Other less common variants of IgG pemphigus include pemphigus herpetiformis, pemphigus erythematosus, pemphigus vegetans, and paraneoplastic pemphigus. The majority (80 percent) of pemphigus is IgG mediated, however IgA has also been described. IgA pemphigus is characterized by a unique histologic pattern, ranging between subcorneal pustular dermatosis (SPD),1-3 to intraepidermal neutrophilic dermatosis (IEN).4-6 SPD typically presents as vesiculopustules in an annular pattern. Direct immunofluorescence demonstrates desmocollin 1 (Dsc1) antigen bound by IgA in the superficial epidermis. IEN manifests as a vesiculopustular eruption but usually has more erythematous plaques. Histology shows intraepidermal pustules. In IEN, the antigen bound by IgA has been found to be Dsg1 or Dsg3.5 Here we present the first North American case in an adult of IgG/IgA pemphigus in which the antibody response is mediated both by IgG and IgA to Dsg1, producing an unusual clinical and histologic picture. To date, there have been only 17 cases in the English literature, mainly in Japan and Europe.8-23


A 67-year-old Caucasian female with past medical history of melanoma was referred to dermatology with a two-week history of a recurrent rash. It initially started on her back, and then spread to her upper chest and upper abdomen. The lesions were vesicular and extremely pruritic. When scratched, the lesions would open to form erosions. She did not report any pain, fever, or any other new symptoms related to the rash. She denied any new medications or other new exposures. On physical exam, she had eruptions of erythematous scaly plaques on her back, chest, anterior neck, inframammary folds, and upper abdomen with several 1-2cm open erosions and superficial ulcerations, many with eschars and excoriation (Figures 1, 2). There were a few tense bullae on her trunk, with a negative Nikolsky’s sign. No erosive lesions were found in the oral mucosa or genital area. A complete metabolic panel was normal.

A biopsy was performed and revealed an intraepidermal pustular dermatosis with both acantholysis and neutrophilic abscesses (Figure 3). Direct immunofluorescence performed on a perilesional site using antibodies for IgG, IgA, IgM, kappa, lambda, C3, and fibrinogen showed an intraepidermal distribution of IgG, IgA, kappa/lambda, and C3 on keratinocyte cell surfaces throughout the epidermis (Figures 4a, 4b). A serum antibody analysis was performed, and the patient’s serum demonstrated positive anti-Dsg1 antibodies with negative antibodies to Dsg3. Based on these findings, a diagnosis of IgG/IgA pemphigus foliaceus was made, and the patient was started on doxycycline 100 mg BID, clobetasol 0.05% ointment, and 500mg niacinamide TID. After one month she noted fewer flares, but was still getting sparse new blisters every two to three days. Additionally, her scalp continued to develop pruritic blisters, which were only partially responsive to treatment with clobetasol twice daily. After 12 months, her condition is stable with fewer erosions on her trunk, but she continues to get flares of scalp vesicles, and reports new lesions on the arms, vaginal area, in the nose, and ears. Very recently, dapsone therapy (50mg daily) has been started with the patient with little therapeutic efficacy. However, upon increasing the dose to 75mg daily, the patient reports that the lesions are starting to respond favorably. The patient continues to be followed in clinic and is slowly improving, and the efficacy of the addition of dapsone to her treatment regimen will be continued to be monitored.


Since the first description of IgG/IgA pemphigus by Nishikawa et al in 1987,7 17 cases have been reported in the English literature. The clinical characteristics of IgA/IgG pemphigus are often similar to that of IgG pemphigus, however, there is significant amount of variability in the clinical and histopathological features of the disease (Table 1). Seven of the cases describe the erythematous lesions as vesicular,9,11,15,16,19,21,22 while eight described the lesions as predominantly pustular. 9,10,12,14,16,17,21,23 Four reports describe oral or genital mucosa involvement.10,13,14,20 Some reports involved a neutrophilic infiltrate,9-15,19,20,21,23 whereas others had an eosinophilic infiltrate.14-16,19,23 Acantholysis was found in about half of the reports.8,9,11-14,17,20,21 Furthermore, in many cases, ELISA and immunoblotting studies were performed to determine the presence of antibodies against specific antigens. The results are very diverse, with both IgA and IgG targeting a variety of intraepidermal proteins. IgA antibodies were found against Dsg1 in 10 reports, 9,11,12,15,16,18,19,21,22, 23 against Dsg3 in five,10,13,14,19,20 against Dsc in three,8,10,17 and in one against desmoplakin (DP),10 Similarly, IgG antibodies were found against Dsg1 in nine reports,9,11,12,15,18,19,21-23 against Dsg3 in five,10,13,14,16,20 against Dsc in five,8,10,12,17,22 and in one against DP.10 Finally, the therapeutic regimens varied between the reports, but the most popular regimens involved the use of dapsone and/or prednisolone.10-23 Some cases also reported using tetracycline,23 minocycline,11 clobetasol ointment,21 or betamethasone ointment.11


While it is unknown why many of the reported cases of IgG/IgA pemphigus originate from Japan and Europe, this condition may simply be under-reported from other parts of the world. Our case marks the first reported case in an adult in North America, and eighteenth report of IgG/IgA pemphigus worldwide. Because the autoantibodies in our patient are against Dsg1 and not Dsg3, the case that we present here has the immunological pattern that is consistent with PF. Of note, however, the histology of this patient’s skin was a blend of that normally found in IgG mediated pemphigus (acantholysis) as well as that of IgA mediated disease (neutrophilic abscesses). Indeed, the presence of IgG and IgA antibodies on keratinocytes, the intradermal pustular dermatitis, and the intracellular neutrophilic abscesses characterizes this case as an extremely atypical, rare variant of pemphigus. Though our patient has improved significantly on her current regimen, the addition of dapsone appears to be having a good therapeutic effect, especially as her symptoms continue to improve. Dapsone has shown excellent results in previous IgG/IgA pemphigus cases. This may be due to the fact that dapsone inhibits neutrophilic adherence to IgG and IgA antibodies,24 which has been demonstrated in this patient’s histology.

The authors have no disclosures.

Daniel Opel, MA is a fourth year medical student at Loyola University Chicago Stritch School of Medicine.

Loebat Julia Kamalpour, MD is a dermatologist at William K. Brokken Dermatology in Santa Barbara, CA.

Laura Winterfield MD, MPH is a dermatologist at Loyola University Chicago Division of Dermatology.

Rebecca Tung, MD is a dermatologist at Loyola University Chicago Division of Dermatology.

Kelli Hutchens, MD is a dermatopathologist at Loyola University of Chicago Department of Pathology.

  1. Wallach D, Cottenot F, Pelbois G, Cavelier B, Didierjean L, Saurat JH. Subcorneal pustular dermatosis and monoclonal IgA. Br J Dermatol. 1982 Aug;107(2):229–34.
  2. Hashimoto T, Kiyokawa C, et al. Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol. 1997 Aug;109(2):127–31.
  3. Yasuda H, Kobayashi H, et al. Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin- 1 and clinical review. Br J Dermatol. 2000 Jul;143(1):144–8
  4. Hashimoto T, Inamoto N, Nakamura K, Nishikawa T. Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis. Arch Dermatol. 1987 Aug;123(8):1062–65
  5. Hashimoto T, Komai A, et al. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus. Arch Dermatol. 2001 Jun;137(6):735–8
  6. Harman KE, Holmes G, Bhogal BS, McFadden J, Black MM. Intercellular IgA dermatosis (IgA pemphigus) – two cases illustrating the clinical heterogeneity of this disorder. Clin Exp Dermatol. 1999 Nov;24(6):464–6
  7. Nishikawa T, Shimizu H, Hashimoto T. Role of IgA intercellular antibodies: report of clinically and immunopathologically atypical cases. Proceedings of the XVII World Congress Dermatol. 1987;383–4
  8. Chorzelski TP, Hashimoto T, et al. Unusual acantholytic bullous dermatosis associated with neoplasia and IgG and IgA antibodies against bovine desmocollins I and II. J Am Acad Dermatol. 1994 Aug;31(2 Pt 2):351–55
  9. Miyagawa S, Hashimoto T, Ohno H, Nakagawa A, Watanabe K, Nishikawa T, Shirai T. Atypical pemphigus associated with monoclonal IgA gammopathy. J Am Acad Dermatol. 1995 Feb;32(2 Pt 2):352-7
  10. Gooptu C, Mendelsohn S, Amagai M, Hashimoto T, Nishikawa T, Wojnarowska F. Unique immunobullous disease in a child with a predominantly IgA response to three desmosomal proteins. Br J Dermatol. 1999 Nov;141(5):882–6
  11. Oiso N, Yamashita C, Yoshioka K, Amagai M, Komai A, Nagata Y, et al. IgG/IgA pemphigus with IgG and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay. Br J Dermatol. 2002 Nov;147(5):1012–17
  12. Kozlowska A, Hashimoto T, Jet al. Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Acad Dermatol. 2003 Jan;48(1): 117– 22
  13. Bruckner AL, Fitzpatrick JE, Hashimoto T, Weston WL, Morelli JG. Atypical IgA/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus? Pediatric Dermatol. 2005 Jul-Aug;22(4):321–7
  14. Morizane S, Yamamoto T, Hisamatsu Y, Tsuji K, Oono T, Hashimoto T, Iwatsuki K. Pemphigus vegetans with IgG and IgA antidesmoglein 3 antibodies. Br J Dermatol. 2005 Dec;153(6):1236-7
  15. Kowalewski C, Hashimoto T, Amagai M, Jablonska S, Mackiewicz W, Wozniak K. IgA/IgG pemphigus: a new atypical subset of pemphigus? Acta Derm Venereol. 2006;86(4):357–8
  16. Inui S, Amagai M, Tsutsui S, Fukuhara-Yoshida S, Itami S, Katayama I. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1. J Am Acad Dermatol. 2006 Aug;55(2):354–5
  17. Heng A, Nwaneshiudu A, Amagai M, Stanley JR. Intrapeidermal neutrophilic IgA/IgG antidesmocollin 1 pemphigus. Br J Dermatol. 2006 May;154(5):1018-20
  18. Maruyama H, Kawachi Y, Fujisawa Y, Itoh S, Furuta J, Ishii Y, et al. IgA/IgG pemphigus positive for anti-desmoglein 1 autoantibody. Eur J Dermatol. 2007 Jan-Feb;17(1):94–5. Epub 2007 Feb 27
  19. Nakajima K, Hashimoto T, Nakajima H, Yokogawa M, Ikeda M, Kodama H. IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses. J Dermatol. 2007 Nov;34(11): 757–60
  20. Zaraa I, Kerkeni N, et al. IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein antibodies detected enzyme-linked immunosorbent assay: a case report and review of the literature. Int J Dermatol. 2010 Mar;49(3):298–302
  21. Santiago-et-Sánchez-Mateos D, Martin A, Gonzalez de Arriba A, Jímenez Y, Fraga J, Hashimoto T, Garcia-Diez A. IgG/IgA pemphigus with IgA and IgG antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay: presentation of two cases. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):110-2
  22. Hosoda S, Suzuki M, Komine M, Murata S, Hashimoto T, Ohtsuki M. A case of IgG/IgA pemphigus presenting malar rash-like erythema. Acta Derm Venereol. 2012 Mar;92(2):164-6
  23. Feng S, Zhi L, Jin P, Zhou W, Yin Y. A case of IgA/IgG pustular pemphigus. Int J Dermatol. 2012 Mar;51(3):321-4
  24. Thuong-Nguyen V, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of neutrophil adherence to antibody by dapsone: A possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol 1993 Apr;100(4):349–55